The ethical issues in the clinical application of stem cells

Authors

  • Fa-guang Huang Department of Surgery, Wuxi County People 's Hospital, No. 100, Wan Tong Road, Wuxi County, Chongqing, China
  • Jian Hu Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China
  • Jia-fu Liu Department of Hepatobiliary Surgery, People's Hospital of Hechuan District, Chongqing Municipality, Hechuan District Yingpan Street No. 172, China
  • Jian Ping Gong Department of Hepatobiliary Surgery, People's Hospital of Hechuan District, Chongqing Municipality, Hechuan District Yingpan Street No. 172, China
  • Yong Liu Department of Hepatobiliary Surgery, People's Hospital of Hechuan District, Chongqing Municipality, Hechuan District Yingpan Street No. 172, China

DOI:

https://doi.org/10.18203/2349-2902.isj20170843

Keywords:

Clinical application, Ethics, Stem cell

Abstract

The current scientific research directing at the stem cells is being a new research hotspot of life science in the 21st century due to its advantages in clinical treatment. While the clinical application of stem cells brings new hope to the patients, it also brings a lot of medical ethics issues. Therefore, it is necessary that making reasonable efforts on the clinical application of stem cells to meet the requirement of normalization and standardization. This paper covers the clinical application of stem cells and the its ethical problems.

References

Shamblott MJ, Axelman J, Wang S, Bugg EM, Littlefield JW, Donovan PJ, et al. Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc Natl Acad Sci. 1998;95:13726-31.

Thomson JA, Eldor IJ, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282:1145-7.

The ethics committee of Chinese National Human Genome Center. Ethical Principle of Human Embryonic Stem Cell Research. Medicine and Philosophy. 2003;24(2):19-21.

China's ministry of science and technology, and ministry of health. Guidelines for Research on Human Embryonic Stem Cells. Chinese J Reproductive Health. 2004;15(2):71.

Yong KW, Choi JR, Wan SWK. Biobanking of human mesenchymal stem cells: future strategy to facilitate clinical applications. Adv Exp Med Biol. 2016;951:99-110.

Franco S, Szczesna K, Iliou MS, Qahtani M, Mobasheri A, Kobolák J, et al. In-vitro models of cancer stem cells and clinical applications. BMC Cancer. 2016;16(2):738.

Wilson G, Hebbard L, Duan W, George J, Qiao L. Induced pluripotent stem cells (iPSCs) in the gastroenterology and hepatology: from basic research to clinical applications. Curr Stem Cell Res Ther. 2015;10(3):190-2.

Wu J, Sun Y, Block TJ, Marinkovic M, Zhang ZL, Chen R, et al. Umbilical cord blood-derived non-hematopoietic stem cells retrieved and expanded on bone marrow-derived extracellular matrix display pluripotent characteristics. Stem Cell Res Ther. 2016;7(1):176.

Wang M, Yang X, Zhang P, Cai L, Yang X, Chen Y, et al. Sustained delivery growth factors with polyethyleneimine-modified nanoparticles promote embryonicstem cells differentiation and liver regeneration. Adv Sci. 2016;3(8):1500393.

Bayer EA, Fedorchak MV, Little SR. The influence of platelet-derived growth factor and bone morphogenetic protein presentation on tubule organization by human umbilical vascular endothelial cells and human mesenchymal stem cells in coculture. Tissue Eng. 2016;22(21):1296-304.

Parfitt DA, Lane A, Ramsden C, Jovanovic K, Coffey PJ, Hardcastle AJ, et al. Using induced pluripotent stem cells to understand retinal ciliopathy disease mechanisms and develop therapies. Biochem Soc Trans. 2016;44(5):1245-51.

Borisov MA, Petrakova OS, Gvazava IG, Kalistratova EN, Vasiliev AV. Stem cells in the treatment of insulin-dependent diabetes mellitus. Acta Naturae. 2016;8(3):31-43.

Mizuno H. Ethical issues for clinical studies that use human embryonic stem cells: the 2014 revisions to the japanese guidelines. Stem Cell Rev. 2015;11(5):676-80.

Monahan P. Developmental biology. human embryo research confronts ethical 'rule'. Science. 2016;352(6286):640.

Zhai X, Ng V, Lie R. No ethical divide between China and the West in human embryo research. Dev World Bioeth. 2016;16(2):116-20.

Qiu RZ, Zhai X. On the ethical supervision and control of stem cell research and clinical application. Chinese Medical Ethics. 2009;22(5):3-9.

Atala A. Tissue engineering of reproductive tissues and organs. Fertil Steril. 2012;98(1):21-9.

Shapshay S. Procreative liberty, enhancement and commodification in the human cloning debate. Health Care Anal. 2012;20(4):356-66.

Maurice R. Social policy group key ethical issues in embryonic stem cell research.Information Research Services. 2002;5:34-7.

Guidelines for the clinical translation of stem cells. ISSCR, Available at www.isscr.org. Accessed on 3 December 2008.

Yu LM, Wei W. Ethical scan on technology of clone. Journal Chongqing Jiaotong University. 2007;7(2):53-5.

Marks NJ. Speech acts and performances of scientific citizenship: Examining how scientists talk about therapeutic cloning. Public Underst Sci. 2014;23(5):494-510.

International society for stem cell research. Guidelines for the clinical translation of stem cells. Available at http:// www.isscr.org /docs/ guidelines/ isscrglclinicaltrans. pdf. Accessed on 3 December 2008.

Hyun I. Allowing innovative stem cell-based therapies outside of clinical trials: ethical and policy challenges. Journal Law, Med Ethics. 2010;38(2):277-85.

Downloads

Published

2017-02-25

Issue

Section

Review Articles